The role of cellular immunity in the protective efficacy of the SARS-CoV-2 vaccine
Several severe acute respiratory Syndrome Coronavirus 2 (SARS CoV-2) vaccines have been approved for clinical use. However, most studies use the SARS-CoV-2-neutralizing antibody titers in duced after immunization as an evaluation indicator, and the role of cellular immune responses in the protective efficacy of vaccines is rarely mentioned. The synergistic effect of virus-specific humor al immunity and the cellular immune response helps the host fight against viral infection. A follow-up analysis of SARS-CoV-2-in fected individuals indicated that the early appearance of specific T cell responses is strongly correlated with mild symptoms and that individuals with pre-existing SARS-CoV-2 nonstructural pro tein-specific T cells are more likely to be immune to infection. These findings suggest the important role of cellular immunity in the fight against SARS-CoV-2 infection.
The role of cellular immunity in the protective efficacy of the SARS-CoV-2 vaccine Read More »